"Urea/therapeutic use"[MAJR] - Search Results

Year	Number of Results
1945	1
1947	1
1948	4
1949	2
1951	1
1952	1
1953	6
1954	5
1955	5
1956	5
1957	10
1958	9
1959	2
1961	3
1962	2
1963	1
1964	3
1965	55
1966	80
1967	109
1968	114
1969	107
1970	163
1971	219
1972	229
1973	239
1974	234
1975	209
1976	230
1977	214
1978	215
1979	206
1980	200
1981	209
1982	202
1983	180
1984	199
1985	169
1986	176
1987	173
1988	176
1989	170
1990	143
1991	174
1992	191
1993	146
1994	131
1995	163
1996	159
1997	160
1998	181
1999	171
2000	205
2001	192
2002	219
2003	229
2004	231
2005	187
2006	210
2007	225
2008	216
2009	212
2010	250
2011	314
2012	419
2013	579
2014	626
2015	658
2016	573
2017	584
2018	585
2019	555
2020	517
2021	405
2022	134
2023	96
2024	409

1

Development and Validation of a Sensitive LC-MS/MS Method for Determination of Lenvatinib and Its Major Metabolites in Human Plasma and Its Application in Hepatocellular Carcinoma Patients.

Guan S, Yuan G, Bi G, Yu Q, Fang JH, Chen J, Bi H. Guan S, et al. J Sep Sci. 2024 Dec;47(23):e70042. doi: 10.1002/jssc.70042. J Sep Sci. 2024. PMID: 39623559

2

Effectiveness of sorafenib in treating intermediate-stage hepatocellular carcinoma patients refractory to transarterial chemoembolization.

Ashour R, Rewisha E, Rady MA, Elkhadry SW, Abdelhalim H, Atef M. Ashour R, et al. BMC Cancer. 2024 Nov 28;24(1):1466. doi: 10.1186/s12885-024-13199-1. BMC Cancer. 2024. PMID: 39609726 Free PMC article.

3

Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia.

Vaddady P, Glatard A, Smania G, Nakayama S, Inoue H, Kurumaddali A, Abutarif M, Zheng M. Vaddady P, et al. Clin Transl Sci. 2024 Dec;17(12):e70074. doi: 10.1111/cts.70074. Clin Transl Sci. 2024. PMID: 39601658 Free PMC article. Clinical Trial.

4

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia.

Ayabe K, Komiyama T, Takekawa H, Kang H, Tsumagari Y, Ito M, Ashikaga K, Shibata Y. Ayabe K, et al. Medicina (Kaunas). 2024 Oct 31;60(11):1782. doi: 10.3390/medicina60111782. Medicina (Kaunas). 2024. PMID: 39596966 Free PMC article.

5

SOCS3 Methylation Partially Mediated the Association of Exposure to Triclosan but Not Triclocarban with Type 2 Diabetes Mellitus: A Case-Control Study.

Gao Q, Huan C, Jia Z, Cao Q, Yuan P, Li X, Wang C, Mao Z, Huo W. Gao Q, et al. Int J Mol Sci. 2024 Nov 11;25(22):12113. doi: 10.3390/ijms252212113. Int J Mol Sci. 2024. PMID: 39596180 Free PMC article.

6

Real-World, Observational, Retrospective Study to Evaluate the Effectiveness and Safety of Treatment with Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Csipak AR, da Fonseca LG, López RVM, Estevez-Diz MDP. Csipak AR, et al. Curr Oncol. 2024 Nov 1;31(11):6778-6790. doi: 10.3390/curroncol31110500. Curr Oncol. 2024. PMID: 39590131 Free PMC article.

7

Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.

Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.

8

Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma.

Han RY, Gan LJ, Lang MR, Ren SH, Liu DM, Li GT, Liu YY, Tian XD, Zhu KW, Sun LY, Chen L, Song TQ. Han RY, et al. World J Gastroenterol. 2024 Nov 21;30(43):4620-4635. doi: 10.3748/wjg.v30.i43.4620. World J Gastroenterol. 2024. PMID: 39575400 Free PMC article.

9

[A Case of Upper Gastrointestinal Perforation during Treatment with Regorafenib for Recurrent Rectal Cancer].

Yoshizawa S, Kazama K, Otani K, Hashimoto I, Kato A, Maezawa Y, Sawazaki S, Aoyama T, Yukawa N, Saito A, Rino Y. Yoshizawa S, et al. Gan To Kagaku Ryoho. 2024 Oct;51(10):1080-1082. Gan To Kagaku Ryoho. 2024. PMID: 39572003 Japanese.

10

Comparative analysis of efficacy and safety between D-TACE + HAIC + lenvatinib and D-TACE + lenvatinib in the treatment of unresectable massive hepatocellular carcinoma.

Lu H, Liang B, Zheng C, Xia X. Lu H, et al. BMC Cancer. 2024 Nov 18;24(1):1422. doi: 10.1186/s12885-024-13179-5. BMC Cancer. 2024. PMID: 39558198 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,995 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,995 results

Results by year